Tumor-infiltrating lymphocytes to predict survival to anthracycline/taxane-based adjuvant chemotherapy in triple negative breast cancer.

被引:0
|
作者
Ou, Qiyun
Yu, Yunfang
Xiao, Xiaoyun
Luo, Baoming
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Ultrasonog, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Tumor-infiltrating lymphocytes to predict survival to anthracycline/taxane-based neoadjuvant chemotherapy in breast cancer.
    Ou, Qiyun
    Yu, Yunfang
    Xiao, Xiaoyun
    Luo, Baoming
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [2] Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer
    West, Nathan R.
    Milne, Katy
    Truong, Pauline T.
    Macpherson, Nicol
    Nelson, Brad H.
    Watson, Peter H.
    [J]. BREAST CANCER RESEARCH, 2011, 13 (06):
  • [3] Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer
    Nathan R West
    Katy Milne
    Pauline T Truong
    Nicol Macpherson
    Brad H Nelson
    Peter H Watson
    [J]. Breast Cancer Research, 13
  • [4] Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer
    Leon-Ferre, Roberto A.
    Polley, Mei-Yin
    Liu, Heshan
    Gilbert, Judith A.
    Cafourek, Victoria
    Hillman, David W.
    Elkhanany, Ahmed
    Akinhanmi, Margaret
    Lilyquist, Jenna
    Thomas, Abigail
    Negron, Vivian
    Boughey, Judy C.
    Liu, Minetta C.
    Ingle, James N.
    Kalari, Krishna R.
    Couch, Fergus J.
    Visscher, Daniel W.
    Goetz, Matthew P.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (01) : 89 - 99
  • [5] Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer
    Roberto A. Leon-Ferre
    Mei-Yin Polley
    Heshan Liu
    Judith A. Gilbert
    Victoria Cafourek
    David W. Hillman
    Ahmed Elkhanany
    Margaret Akinhanmi
    Jenna Lilyquist
    Abigail Thomas
    Vivian Negron
    Judy C. Boughey
    Minetta C. Liu
    James N. Ingle
    Krishna R. Kalari
    Fergus J. Couch
    Daniel W. Visscher
    Matthew P. Goetz
    [J]. Breast Cancer Research and Treatment, 2018, 167 : 89 - 99
  • [6] Tumor-infiltrating lymphocytes in triple negative breast cancer
    Zakhartseva, L. M.
    Yanovytska, M. O.
    [J]. PATHOLOGIA, 2020, (03): : 287 - 294
  • [9] Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
    Leon-Ferre, Roberto A.
    Jonas, Sarah Flora
    Salgado, Roberto
    Loi, Sherene
    de Jong, Vincent
    Carter, Jodi M.
    Nielsen, Torsten O.
    Leung, Samuel
    Riaz, Nazia
    Chia, Stephen
    Jules-Clement, Gerome
    Curigliano, Giuseppe
    Criscitiello, Carmen
    Cockenpot, Vincent
    Lambertini, Matteo
    Suman, Vera J.
    Linderholm, Barbro
    Martens, John W. M.
    van Deurzen, Carolien H. M.
    Timmermans, A. Mieke
    Shimoi, Tatsunori
    Yazaki, Shu
    Yoshida, Masayuki
    Kim, Sung-Bae
    Lee, Hee Jin
    Dieci, Maria Vittoria
    Bataillon, Guillaume
    Vincent-Salomon, Anne
    Andre, Fabrice
    Kok, Marleen
    Linn, Sabine C.
    Goetz, Matthew P.
    Michiels, Stefan
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (13): : 1135 - 1144
  • [10] Breast Cancer Molecular Subtypes Predict Response to Anthracycline/Taxane-Based Chemotherapy
    Parker, J. S.
    Prat, A.
    Cheang, M. C. U.
    Lenburg, M. E.
    Paik, S.
    Perou, C. M.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 598S - 598S